MTNB - Matinas Biopharma Holdings Inc
Previous close
0.0933
0 0%
Share volume: 2,782,075
Last Updated: Tue 27 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-11 | 2022-11-02 | 2023-03-15 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-27 | |
| Total revenue | 0.000 | 1.063 M | 1.063 M | 1.063 M | 1.096 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 1.063 M | 1.063 M | 1.063 M | 1.096 M | 0.000 | 0.000 | 0.000 | |
| inf% | 0.00% | 0.05% | 3.10% | -100.00% | nan% | nan% | |||
| Operating expenses | 7.722 M | 6.988 M | 6.525 M | 6.543 M | 6.682 M | 6.159 M | 6.134 M | 5.887 M | |
| Selling general and admin | 2.744 M | 2.861 M | 2.818 M | 2.676 M | 2.712 M | 2.600 M | 2.839 M | 2.222 M | |
| Research and development | 4.978 M | 4.127 M | 3.707 M | 3.867 M | 3.970 M | 3.559 M | 3.295 M | 3.665 M | |
| Total expenses | 7.722 M | 6.988 M | 6.525 M | 6.543 M | 6.682 M | 6.159 M | 6.134 M | 5.887 M | |
| -9.51% | -6.62% | 0.27% | 2.13% | -7.83% | -0.41% | -4.03% | |||
| Operating income | -7.722 M | -5.925 M | -5.463 M | -5.480 M | -5.586 M | -6.159 M | -6.134 M | -5.887 M | |
| Ebit | -7.722 M | -5.925 M | -5.463 M | -5.480 M | -5.586 M | -6.159 M | -6.134 M | -5.887 M | |
| Pretax income | -5.978 M | -5.923 M | -5.462 M | -3.635 M | -5.513 M | -6.060 M | -6.055 M | -5.314 M | |
| -0.93% | -7.78% | -33.45% | 51.68% | 9.92% | -0.08% | -12.24% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -5.978 M | -5.923 M | -5.462 M | -3.635 M | -5.513 M | -6.060 M | -6.055 M | -5.314 M | |
| 0.93% | 7.78% | 33.45% | -51.68% | -9.92% | 0.08% | 12.24% | |||
| Net income | -5.978 M | -5.923 M | -5.462 M | -3.635 M | -5.513 M | -6.060 M | -6.055 M | -5.314 M | |
| 0.93% | 7.78% | 33.45% | -51.68% | -9.92% | 0.08% | 12.24% |